Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2001
10/17/2001EP1144640A2 Nucleic acids and proteins from streptococcus pneumoniae
10/17/2001EP1144614A2 33 human secreted proteins
10/17/2001EP1144443A2 Human membrane transport proteins
10/17/2001EP1144435A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1144426A2 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
10/17/2001EP1144425A1 Derivatives of monosaccharides as cell adhesion inhibitors
10/17/2001EP1144411A1 Antihistaminic spiro compounds
10/17/2001EP1144409A2 Phenyl urea and phenyl thiourea derivatives
10/17/2001EP1144403A1 Substitued pyrazoles as p38 kinase inhibitors
10/17/2001EP1144402A2 Substituted oximes and hydrazones as neurokinin antagonists
10/17/2001EP1144397A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
10/17/2001EP1144393A2 Heterocyclic derivatives and their use as integrin inhibitor
10/17/2001EP1144390A2 Kinase inhibitors
10/17/2001EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001EP1144387A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
10/17/2001EP1144385A1 Benzoheterocycles and their use as mek inhibitors
10/17/2001EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001EP1144364A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1144362A1 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
10/17/2001EP1144305A1 NOVEL sPLA 2 INHIBITORS
10/17/2001EP1143973A2 Compositions having improved stability
10/17/2001EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001EP1143952A2 Method and composition for treating and preventing tuberculosis
10/17/2001EP1143949A2 19-nor-vitamin d3 compounds with calcemic activity
10/17/2001EP1143946A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
10/17/2001EP1143932A1 Transnasal transport/immunisation with highly adaptable carriers
10/17/2001EP1143930A2 Pharmaceutical formulation of fluticasone propionate
10/17/2001EP1143928A1 Milling process for the production of finely milled medicinal substances
10/17/2001EP1143896A1 Methods of hydrating mucosal surfaces
10/17/2001EP1001955B1 1,2,4-triazolo 4,3-b]pyrido 3,2-d]pyridazine derivatives and pharmaceutical compositions containing them
10/17/2001EP0808103A4 Protein hydroxylation inhibitors for fibroproliferative disorders
10/17/2001EP0640065B1 Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation
10/17/2001CN1318103A Nucleic acids and proteins from streptococcus pneumoniae
10/17/2001CN1318054A Novel compounds
10/17/2001CN1318053A Cyclopentanoue dihydropyridine compounds useful as potassium channel openers
10/17/2001CN1317965A Compounds having IgE affecting properties
10/17/2001CN1317324A Oral liquid for warming lung and dispelling cold and its preparing process
10/17/2001CN1317317A 'Lifeiqing' capsule for treating pulmonary tuberculosis
10/17/2001CN1073115C WS7622A mono-or di-sulfate process for prepn. thereof
10/17/2001CN1073103C Compounds and compsns. for treating diseases associated with tryptase activity
10/17/2001CN1073098C Benzothiazolone derivatives
10/17/2001CN1072957C Externally-used medicine for pharyngitis
10/17/2001CN1072952C Traditional Chinese medicinal pills for treating chronic pharyngitis
10/17/2001CN1072951C Qingyin injection for clearing heat and resisting infection and its preparing process
10/16/2001US6303789 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
10/16/2001US6303648 Methods and compositions for the treatment and prevention of lung disease
10/16/2001US6303643 Therapy of migraine headache, hypertension, alcohol withdrawal, drug addiction, rheumatoid arthritis, presbyopia, ischemic pain, spasticity, diarrhea, nasal congestion, and urinary incontinence by administering benzothiazole derivative
10/16/2001US6303642 Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid as a mucolytic agents
10/16/2001US6303637 For therapy of autoimmune disease, prophylaxis of resistance to transplantation or transplantation rejection of organs or tissues; suppressing immune system
10/16/2001US6303613 As nitric oxide synthase inhibitor useful in therapy or prophylaxis of inflammatory disease and pain
10/16/2001US6303612 Derivatives of hydroxyphenylsulfanylbenzoic and hydroxphenylsulfanylarylacetic acids
10/16/2001US6303608 2-{4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use
10/16/2001US6303601 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
10/16/2001US6303600 Substituted azabicyclic compounds
10/16/2001US6303595 Use of mirtazapine for treating sleep apneas
10/16/2001US6303127 Treatment of disease states
10/16/2001US6303126 Treatment of fibrosis by HGF
10/16/2001US6303103 1,1,1,2-tetrafluoroethane as propellant; inhalants.
10/16/2001CA2036977C Imidazopyridazines, their production and use
10/16/2001CA2015470C Fluorinated arachidonic acid derivatives
10/11/2001WO2001074903A2 CD20/IgE-RECEPTOR LIKE MOLECULES AND USES THEREOF
10/11/2001WO2001074896A1 Human polynucleotides, polypeptides, and antibodies
10/11/2001WO2001074811A2 Substituted 1,3-thiazole compounds, their production and use
10/11/2001WO2001074806A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001WO2001074780A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
10/11/2001WO2001074769A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/11/2001WO2001074763A1 Aryl and heteroaryl sulfonates
10/11/2001WO2001074506A1 Extrusion die
10/11/2001WO2001074432A1 Microencapsulated fragrances and methods of coating microcapsules
10/11/2001WO2001074413A1 Medical devices suitable for gene therapy regimens
10/11/2001WO2001074404A2 Compositions containing genetically modified lung cancer cells expressing a tgf-beta inhibitor
10/11/2001WO2001074386A2 Cold-adapted equine influenza viruses
10/11/2001WO2001074344A2 Small organic molecule regulators of cell proliferation
10/11/2001WO2001074341A2 Composition for treating allergic and inflammatory conditions with cough containing a non-sedating histamine and an expectorant
10/11/2001WO2001049319A8 Composition containing bacterial antigens, used for the prophylaxis and the treatment of allergic diseases
10/11/2001WO2001034572A3 Carboxamide-substituted benzimidazol derivatives, method for the production thereof and their use as tryptase inhibitors
10/11/2001WO2001028556A3 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use
10/11/2001WO2001025269A3 Human g-protein coupled receptor
10/11/2001WO2001025210A3 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands
10/11/2001WO2001022956A3 NOVEL COMBINATION OF LOTEPREDNOL AND β2-ADRENOCEPTOR AGONISTS
10/11/2001WO2001021587A3 Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors
10/11/2001WO2001019826A3 Triazolopyrimidine derivatives
10/11/2001WO2000062736A3 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/11/2001US20010029249 Adenovirus comprising a gene coding for glutathione peroxidase
10/11/2001US20010028899 Composition for supprssing cellular fibrousing and method for preparing an extract from loquat seeds
10/11/2001DE10015866A1 Aryl- und Heteroarylsulfonate Aryl and Heteroarylsulfonate
10/11/2001CA2404545A1 Aryl and heteroaryl sulfonates
10/11/2001CA2404413A1 Small organic molecule regulators of cell proliferation
10/11/2001CA2404384A1 Substituted 1,3-thiazole compounds, their production and use
10/11/2001CA2404300A1 Medical devices suitable for gene therapy regimens
10/11/2001CA2404074A1 Human polynucleotides, polypeptides, and antibodies
10/11/2001CA2403979A1 Cold-adapted equine influenza viruses
10/11/2001CA2403885A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
10/11/2001CA2403600A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001CA2401948A1 Cd20/ige-receptor like molecules and uses thereof
10/11/2001CA2401137A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/10/2001EP1142890A1 Aminopyrazole derivatives
10/10/2001EP1142889A1 Pyrazole derivatives as anti-inflammatory/analgesic agents
10/10/2001EP1142875A1 Cinnamamide derivatives and drug compositions containing the same
1 ... 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 ... 878